Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System

Detalles Bibliográficos
Autores principales: Wang, Tiansheng, Lu, Wenchao, Tang, Huilin, Buse, John B., Stürmer, Til, Gower, Emily W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2019
Materias:
e-Letters: Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341287/
https://www.ncbi.nlm.nih.gov/pubmed/30530488
http://dx.doi.org/10.2337/dc18-1893
_version_ 1783388931565289472
author Wang, Tiansheng
Lu, Wenchao
Tang, Huilin
Buse, John B.
Stürmer, Til
Gower, Emily W.
author_facet Wang, Tiansheng
Lu, Wenchao
Tang, Huilin
Buse, John B.
Stürmer, Til
Gower, Emily W.
author_sort Wang, Tiansheng
collection PubMed
description
format Online
Article
Text
id pubmed-6341287
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-63412872020-02-01 Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System Wang, Tiansheng Lu, Wenchao Tang, Huilin Buse, John B. Stürmer, Til Gower, Emily W. Diabetes Care e-Letters: Observations American Diabetes Association 2019-02 2018-12-07 /pmc/articles/PMC6341287/ /pubmed/30530488 http://dx.doi.org/10.2337/dc18-1893 Text en © 2018 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle e-Letters: Observations
Wang, Tiansheng
Lu, Wenchao
Tang, Huilin
Buse, John B.
Stürmer, Til
Gower, Emily W.
Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
title Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
title_full Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
title_fullStr Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
title_full_unstemmed Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
title_short Assessing the Association Between GLP-1 Receptor Agonist Use and Diabetic Retinopathy Through the FDA Adverse Event Reporting System
title_sort assessing the association between glp-1 receptor agonist use and diabetic retinopathy through the fda adverse event reporting system
topic e-Letters: Observations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341287/
https://www.ncbi.nlm.nih.gov/pubmed/30530488
http://dx.doi.org/10.2337/dc18-1893
work_keys_str_mv AT wangtiansheng assessingtheassociationbetweenglp1receptoragonistuseanddiabeticretinopathythroughthefdaadverseeventreportingsystem
AT luwenchao assessingtheassociationbetweenglp1receptoragonistuseanddiabeticretinopathythroughthefdaadverseeventreportingsystem
AT tanghuilin assessingtheassociationbetweenglp1receptoragonistuseanddiabeticretinopathythroughthefdaadverseeventreportingsystem
AT busejohnb assessingtheassociationbetweenglp1receptoragonistuseanddiabeticretinopathythroughthefdaadverseeventreportingsystem
AT sturmertil assessingtheassociationbetweenglp1receptoragonistuseanddiabeticretinopathythroughthefdaadverseeventreportingsystem
AT goweremilyw assessingtheassociationbetweenglp1receptoragonistuseanddiabeticretinopathythroughthefdaadverseeventreportingsystem

Ejemplares similares